LBX Pharmacy Chain JSC
SSE:603883
LBX Pharmacy Chain JSC
Interest Income Expense
LBX Pharmacy Chain JSC
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LBX Pharmacy Chain JSC
SSE:603883
|
Interest Income Expense
-¥118.1m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Interest Income Expense
-¥188.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-71%
|
CAGR 10-Years
N/A
|
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
|
Interest Income Expense
-¥92.1m
|
CAGR 3-Years
-178%
|
CAGR 5-Years
-92%
|
CAGR 10-Years
N/A
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Interest Income Expense
-¥41.3m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
|
Interest Income Expense
-¥101m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Interest Income Expense
-¥61.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
See Also
What is LBX Pharmacy Chain JSC's Interest Income Expense?
Interest Income Expense
-118.1m
CNY
Based on the financial report for Mar 31, 2024, LBX Pharmacy Chain JSC's Interest Income Expense amounts to -118.1m CNY.
What is LBX Pharmacy Chain JSC's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-22%
Over the last year, the Interest Income Expense growth was 43%. The average annual Interest Income Expense growth rates for LBX Pharmacy Chain JSC have been -16% over the past three years , -22% over the past five years .